Neocate LCP, the UK’s No.1 AAF1
Neocate LCP is a hypoallergenic amino acid formula designed to meet the nutritional needs of infants who have Cow’s Milk Allergy (CMA), Multiple Food Protein Allergies (MFPA) or require an amino acid formula from birth.
Neocate LCP can be used as a sole source of nutrition up to the age of 1 year. It can be used in combination with breast milk and/or diet during or after weaning. Neocate LCP is the only AAF with 35 years clinical experience and is the most researched formula available in the UK market. More publications (>95) support the use of Neocate than any other hypoallergenic amino acid-based product.
Neocate LCP provides fast and effective resolution of CMA symptoms in 3 to 14 days2,3. Within 3 days on Neocate, studies showed significant improvement of eczema and disappearance of other symptoms (e.g. vomiting, diarrhoea)2. Within 14 days on Neocate, studies showed resolution of all gastrointestinal symptoms. 100% of infants gained weight whilst receiving the AAF3.
Neocate LCP can resolve symptoms unresolved on an eHF*.4 Up to 10% of infants with uncomplicated CMA and up to 40% of infants with more complex allergy may be intolerant to an eHF.4 AAF formulas were found to be effective where symptoms persisted with an eHF. Guidelines suggest that symptoms should resolve within 2-4 weeks on an eHF and if still persisting an AAF should be considered.5
Neocate LCP supports growth vs an eHF6
Neocate LCP is the only Amino Acid Formula (AAF) that:
- contains LCPs in line with EFSA recommendations for the visual development of infants and in a 1:1 ratio7,8
- is part of an age-adapted range of products
*Extensively Hydrolysed Formula
Accurate at time of publication, November 2020
IMPORTANT NOTICE: Breastfeeding is best. Neocate LCP is a food for special medical purposes for the dietary management of Cow’s Milk Allergy, Multiple Food Protein Allergies and other conditions where an amino acid based formula is recommended. It should only be used under medical supervision, after full consideration of the feeding options available including breastfeeding. Suitable for use as the sole source of nutrition for infants under one year of age. Refer to label for details.
- IMS data, MAT January 2020, volume AAF market share.
- De Boissieu et al. Allergy to extensively hydrolysed cow milk proteins in infants: Identification and treatment with an amino acid-based formula. J. Pediatrics 1997 131 (5) 744-747.
- Vanderhoof, J.A. et al. Intolerance to protein hydrolysate infant formulas: An under recognized cause of gastrointestinal symptoms in infants. J. Pediatrics 1997 131(5) 741-4.
- Hill DJ et al. The efficacy of amino acid-based formulas in relieving the symptoms of cow's milk allergy: a systematic review. Clin Exp Allergy 2007; 37, 808-822. Venter C et al. Diagnosis and management of non IgE mediated CMA in infancy - a UK primary care practical guide. Clin Translational Allergy 2013; 12: 23.
- Venter et al. Clinical and translational allergy 2013; 3(1): 23
- Isolauri E et al. Efficacy and safety of hydrolyzed cow milk and amino acid-derived formulas in infants with cow milk allergy. J Pediatr 1995;127(4):550-557
- European food safety authority, DHA and ARA and Visual Development, the EFSA journal 2009;94:1-14
- Haribige L.S. Fatty acids, the immune response and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3, Lipids 2003;38(4):323-341